OrthoAccel Finds $10M

Houston-based OrthoAccel Technologies, the developer of an FDA-cleared device which helps speed up orthodontic procedures by accelerating teeth movement, has raised $10M in a growth capital funding, the firm said today. The round was led by HealthpointCapital Partners, and also included S3 Ventures. As part of the funding, John McCormick of HealthpointCapital has joined the company's board. OrthoAccel's device was cleared in an FDA 510(k) approval in November of 2011. The company says its device requires only about 20 minutes a day to accelerate the treatment time for wearing braces; the device has bene rolling out in the United Kingdom, Australia, France, Italy, and other countries since 2010. More information »